Largest MRNA therapeutics Companies by Market Cap (April 2025)

As of April 24, 2025, we have calculated the total market capitalization of 4 publicly traded MRNA therapeutics companies, amounting to $40.65 billion.

$40.65 B

MRNA therapeutics Market Cap 12.40%

$6828814.0

24h Trading Volume

According to our market capitalization data, BioNTech (BNTX) reached a market cap of $28.98 billion, securing the top spot among global MRNA therapeutics companies. Moderna (MRNA) and Curevac (CVAC) follow closely behind. The data was last updated on April 24, 2025.

Rank	Name	Market Cap	Price	MCap(30D)	MCap(1Y)	Country
1	BioNTech BNTX	$28.98 B	$120.54	0.00%	38.2%	Germany
2	Moderna MRNA	$10.59 B	$27.39	-15.7%	-75.0%	United States
3	Curevac CVAC	$0.73 B	$3.26	0.00%	58.0%	Germany
4	Arcturus Therapeutics ARCT	$0.35 B	$12.89	0.00%	-38.4%	United States

This list ranks the largest MRNA therapeutics companies in the world by market capitalization, based on data from publicly traded MRNA therapeutics companies. The market cap figures and rankings on this list are updated daily.

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at hello@topmarketcap.net.

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe

Asia

Others

Largest MRNA therapeutics Companies by Market Cap (April 2025)